Atika Capital Management’s DexCom DXCM Stock Holding History

Atika Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-87,000	Closed	-$5.83M	–	94
2024 Q3	$5.83M	Hold	87,000	–	–	0.6%	52
2024 Q2	$9.86M	Sell	87,000 -16,000	-16%	-$2.02M	0.97%	33
2024 Q1	$14.3M	Hold	103,000	–	–	1.41%	23
2023 Q4	$12.8M	Buy	103,000 +31,000	+43%	+$3.17M	1.71%	20
2023 Q3	$6.72M	Sell	72,000 -31,000	-30%	-$3.49M	0.88%	45
2023 Q2	$13.2M	Sell	103,000 -7,060	-6%	-$854K	1.32%	24
2023 Q1	$12.8M	Sell	110,060 -31,575	-22%	-$3.53M	1.89%	14
2022 Q4	$16M	Buy	+141,635	New	+$15.5M	2.31%	12
2022 Q2	–	Sell	-51,600	Closed	-$6.6M	–	80
2022 Q1	$6.6M	Sell	51,600 -6,000	-10%	-$656K	0.56%	54
2021 Q4	$7.73M	Buy	57,600 +18,800	+48%	+$2.7M	0.54%	65
2021 Q3	$5.3M	Buy	38,800 +34,800	+870%	+$4.39M	0.32%	92
2021 Q2	$427K	Hold	4,000	–	–	0.03%	94
2021 Q1	$360K	Buy	+4,000	New	+$375K	0.03%	90
2020 Q4	–	Sell	-112,000	Closed	-$11.5M	–	120
2020 Q3	$11.5M	Sell	112,000 -4,000	-3%	-$418K	0.95%	38
2020 Q2	$11.8M	Sell	116,000 -64,000	-36%	-$5.72M	1.52%	17
2020 Q1	$12.1M	Sell	180,000 -8,000	-4%	-$498K	2.32%	10
2019 Q4	$10.3M	Buy	188,000 +20,000	+12%	+$949K	1.99%	14
2019 Q3	$6.27M	Sell	168,000 -40,000	-19%	-$1.55M	1.32%	30
2019 Q2	$7.79M	Sell	208,000 -112,000	-35%	-$3.52M	1.53%	24
2019 Q1	$9.53M	Sell	320,000 -38,000	-11%	-$1.34M	1.94%	12
2018 Q4	$10.7M	Sell	358,000 -110,000	-24%	-$3.49M	3.16%	4
2018 Q3	$16.7M	Buy	468,000 +168,000	+56%	+$5.21M	3%	4
2018 Q2	$7.12M	Buy	300,000 +172,000	+134%	+$3.65M	1.37%	20
2018 Q1	$2.37M	Buy	+128,000	New	+$1.89M	0.81%	47

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Atika Capital Management's DXCM Position: Q4 2024 in Review

Atika Capital Management sold out of DexCom (DXCM) in Q4 2024, closing a stake of 87,000 shares — an estimated $5.83M sold.

Atika Capital Management first reported a position in DXCM in Q1 2018 and held it in 24 quarters. The position peaked at $16.7M in Q3 2018. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

Atika Capital Management reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
Atika Capital Management sold 87,000 DexCom shares in Q4 2024, an estimated $5.83M.
Atika Capital Management first reported a position in DexCom in Q1 2018 and held it in 24 quarters.
Atika Capital Management's DexCom position peaked at $16.7M in Q3 2018.
950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Atika Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.